Company intelligence / Profile preview

Neomics Pharmaceuticals

Rockville, Maryland, United States

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Pre-clinical stage biotech developing next-generation CAR-T therapies with 3rd-generation chimeric proteins and ICS for improved efficacy in solid and blood cancers.

Therapeutic areas: OncologyHematology
Modalities: CAR-T cell therapy
Industry: Biotech

Drug pipeline

1 asset

NPB5005-V283

Unknown

Beyond the preview

Go deeper on Neomics Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neomics Pharmaceuticals.

Explore the full profile